Latest Chronic Kidney Disease (CKD) News
The medications are associated with reduced odds of kidney failure and death compared with angiotensin II receptor blockers.
CKD progression from stage 3 to stage 4 also was associated with increased risks of acute kidney injury and hospitalization.
Patients treated with the uric acid-lowering drug were less likely to experience a greater than 10% decline in eGFR than placebo recipients.
Left ventricular hypertrophy is associated with a 4.5 times increased risk of rapid kidney function decline.
A low protein diet of vegetable proteins along with reduced intake of specific micronutrients should be recommended to stage 3-4 CKD patients, researchers say.
As of 2014, rate is 16.8% but big socioeconomic disparities remain.
Each standard deviation increment in pulse pressure and pulse wave velocity is associated with an 11% and 7% increased risk of CKD, respectively.
Long-term statin treatment cut the rates of major adverse cardiovascular events by 20.5%, all-cause mortality by 28.6%.
Researchers also observe an increased risk of early death from any cause.
Personalized medications based on a patient's medical and biological profiles may be possible with 3D printing.
Greater frequency of attending appointments; no difference in the incidence of composite outcomes.
Five hours or less a night linked to reduced organ function in women.
It develops in 8% of patients overall and 15.1% of patients with stage 5 CKD.
The risk of dying following a hip fracture was 6.5 times higher for patients with severe CKD than for those with normal kidney function or mild CKD.
High levels of soluble urokinase-type plasminogen activator receptor are associated with an elevated CKD risk in individuals with normal eGFR.
Chronic Kidney Disease (CKD) Videos
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)